Patients recovering from exacerbations of COPD with and without hospitalization need: could ICF score be an additional pulmonary rehabilitation outcome?


Journal

Annals of medicine
ISSN: 1365-2060
Titre abrégé: Ann Med
Pays: England
ID NLM: 8906388

Informations de publication

Date de publication:
12 2021
Historique:
entrez: 22 3 2021
pubmed: 23 3 2021
medline: 15 12 2021
Statut: ppublish

Résumé

To compare disability changes measured with the Respiratory ICF Maugeri core set on COPD patients, recovering from acute exacerbation with and without hospitalization, submitted to pulmonary rehabilitation (PR). All COPD inpatients admitted for rehabilitation in 9 Respiratory Units (January-August 2019) were considered eligible. 2066 patients were included (540 discharged from an acute Hospital = Hospital group and 1526 coming from their home = Home group). Healthcare professionals filled, in a digitalized chart, the Respiratory ICF Maugeri core set (26 items), assessing ICF categories at admission and discharge. The baseline distribution of the more severe ICF qualifiers was higher in the Hospital group ( Disability measured with the "Respiratory ICF Maugeri core set" after PR improves in COPD patients recovering from acute exacerbation irrespective of hospitalization need. Its use an additional outcome remains to be further elucidated.KEY MESSAGESRoutine implementation of an ICF set for chronic respiratory diseases can enhance a patient-centered approach in rehabilitation for different severity conditions.Pulmonary rehabilitation (PR) seems to improve global disability measured with the Respiratory ICF Maugeri core set in COPD patients recovering from acute exacerbation irrespective of hospitalization need, suggesting the use of ICF set as additional PR outcome.The description, through the ICF language, of rehabilitative needs of patients, coming "from-Home" and "from-Hospital" settings, could help staff and instrument organization.

Identifiants

pubmed: 33749452
doi: 10.1080/07853890.2021.1900592
pmc: PMC7993391
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

470-477

Références

Eur J Phys Rehabil Med. 2017 Feb;53(1):139-143
pubmed: 28145399
Intern Med J. 2009 Aug;39(8):495-501
pubmed: 19732197
Int J Chron Obstruct Pulmon Dis. 2016 Jun 07;11:1199-206
pubmed: 27354778
Disabil Rehabil. 2002 Nov 20;24(17):932-8
pubmed: 12523361
Eur J Intern Med. 2019 Mar;61:1-8
pubmed: 30389274
J Am Geriatr Soc. 1995 Feb;43(2):130-7
pubmed: 7836636
Respir Med. 2009 Oct;103(10):1526-31
pubmed: 19447015
Int J Chron Obstruct Pulmon Dis. 2020 May 29;15:1191-1198
pubmed: 32581526
Minerva Med. 2020 Jun;111(3):239-244
pubmed: 31638363
Am J Respir Crit Care Med. 1997 Feb;155(2):555-61
pubmed: 9032194
Eur Respir J. 2009 Sep;34(3):648-54
pubmed: 19720809
Eur Respir J. 2016 May;47(5):1336-41
pubmed: 27132269
Arch Phys Med Rehabil. 2019 Dec;100(12):2334-2345
pubmed: 30986412
G Ital Med Lav Ergon. 2019 May;41(2):78-104
pubmed: 31170337
JAMA. 2020 May 12;323(18):1813-1823
pubmed: 32396181
Eur J Phys Rehabil Med. 2019 Jun;55(3):384-394
pubmed: 30990004
Int J Chron Obstruct Pulmon Dis. 2020 Oct 21;15:2591-2599
pubmed: 33116476
Respirology. 2008 Nov;13(6):856-62
pubmed: 18811884
Eur J Phys Rehabil Med. 2020 Apr;56(2):252-254
pubmed: 31797657
Eur Respir J. 1998 Aug;12(2):363-9
pubmed: 9727786
J Rehabil Med. 2004 Jul;(44 Suppl):114-20
pubmed: 15370758
J Rehabil Med. 2004 Jul;(44 Suppl):9-11
pubmed: 15370742
J Rehabil Med. 2018 Apr 18;50(4):309-316
pubmed: 28140419
Int J Chron Obstruct Pulmon Dis. 2009;4:315-9
pubmed: 19750191
G Ital Med Lav Ergon. 2019 May;41(2):150-155
pubmed: 31170346

Auteurs

Michele Vitacca (M)

Istituti Clinici Scientifici Maugeri IRCCS, Respiratory Rehabilitation of the Institute of Lumezzane, Brescia, Italy.

Laura Comini (L)

Istituti Clinici Scientifici Maugeri IRCCS, Scientific Direction of the Institute of Lumezzane, Brescia, Italy.

Anna Giardini (A)

Istituti Clinici Scientifici Maugeri IRCCS, IT Department, Pavia, Italy.

Adriana Olivares (A)

Istituti Clinici Scientifici Maugeri IRCCS, Scientific Direction of the Institute of Lumezzane, Brescia, Italy.

Giacomo Corica (G)

Istituti Clinici Scientifici Maugeri IRCCS, Health Directorate of the Institute of Lumezzane, Brescia, Italy.

Mara Paneroni (M)

Istituti Clinici Scientifici Maugeri IRCCS, Respiratory Rehabilitation of the Institute of Lumezzane, Brescia, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH